Form 4: Dycom Director Stephen LeClair Granted Restricted Stock Units

Dycom Industries Director Stephen O. LeClair received a grant of 337 restricted stock units, vesting in November 2026.

Summary

• Stephen O. LeClair, a Director of Dycom Industries, Inc. (DY), was granted 337 Restricted Stock Units (RSUs) on November 7, 2025.
• No consideration was paid for these restricted stock units.
• Each RSU represents a contingent right to acquire one share of Dycom Industries, Inc. common stock.
• The granted RSUs are scheduled to vest in a single annual installment on November 7, 2026.
• Following this transaction, Stephen O. LeClair directly beneficially owns 337 restricted stock units.
• A Power of Attorney was executed on November 7, 2025, by Stephen O. LeClair, appointing Ryan F. Urness and H. Andrew DeFerrari as attorneys-in-fact to execute Section 16 filings on his behalf.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The RSU grant is a standard compensation practice for a director, aligning interests with shareholders. It does not indicate any negative operational or financial news.

Positives

• The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The transaction represents standard compensation practice for non-employee directors, indicating continuity in corporate governance and incentive structures.

Negatives

• No direct negatives are associated with this specific RSU grant, as it is a routine compensation event.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's operational or financial performance, beyond the vesting schedule of the granted RSUs.

Management Comments

• Stephen O. LeClair granted a Power of Attorney to Ryan F. Urness and H. Andrew DeFerrari to execute Forms 3, 4, and 5 on his behalf, acknowledging that the attorneys-in-fact are not assuming his Section 16 compliance responsibilities.

Industry Context

This RSU grant is a routine compensation event for a director, consistent with common practices across publicly traded companies to incentivize and retain board members by aligning their financial interests with long-term shareholder value. It does not reflect broader industry trends or competitive positioning.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) as part of director compensation is a widely adopted practice among U.S. public companies, including those in the infrastructure services sector like Dycom Industries. Companies such as Quanta Services, Inc. (PWR) and MasTec, Inc. (MTZ), often utilize equity-based compensation to align director incentives with long-term shareholder value.
• The specific number of RSUs (337) and the vesting schedule (one annual installment) are typical for non-executive director compensation, reflecting a standard approach to retain and reward board members without immediate cash outlay.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of RSUs to a director is a form of equity compensation that aligns the director's financial interests with long-term shareholder value. It also represents a minor potential for future share dilution upon vesting.
• Management: The Power of Attorney facilitates compliance with regulatory filings for the director, potentially reducing administrative burden on the director while ensuring company personnel can manage the filing process.

Next Steps

• The 337 Restricted Stock Units are scheduled to vest on November 7, 2026, at which point they will convert into shares of common stock, subject to the terms of the grant.

Key Dates

Keywords

Dycom Industries, DY, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, SEC Form 4, Corporate Governance